TAM infiltration into mouse liver cancers was inhibited by RFA treatment or MELK knockdown, with increased M1 macrophages, decreased M2 macrophages in the TAM cluster, and increased CD8+ T cell infiltration. The gene discussed is MELK; the disease is liver cancer.